Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2

NCT07263308 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT07263308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07263308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
Lead sponsor
Capital Medical University
Phase
Phase 3
Overall status
Recruiting
Start date
December 18, 2025
Completion date
December 1, 2027
Enrollment
1,192 (estimated)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke